Mrv1909 12031915152D 18 17 0 0 0 0 999 V2000 0.0000 -2.0625 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -1.4290 2.8876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 1.6501 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8579 -2.0625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -0.8250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.8580 2.0625 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 -0.7145 -0.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4290 -2.8876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.4290 -2.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 1.6501 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.4290 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4290 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4290 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4290 -2.0625 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.7145 -1.6501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 -1.6501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -1.6501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 16 1 0 0 0 0 1 17 1 0 0 0 0 2 14 1 0 0 0 0 3 14 2 0 0 0 0 4 18 1 0 0 0 0 5 18 2 0 0 0 0 11 6 1 6 0 0 0 7 13 1 0 0 0 0 7 17 2 0 0 0 0 15 8 1 1 0 0 0 9 17 1 0 0 0 0 10 11 1 0 0 0 0 10 12 1 0 0 0 0 11 14 1 0 0 0 0 12 13 1 0 0 0 0 15 16 1 0 0 0 0 15 18 1 0 0 0 0 M CHG 1 6 1 M END > DB04671 > drugbank > N[C@@H](CS\C(N)=N\CCC[C@H]([NH3+])C(O)=O)C(O)=O > InChI=1S/C9H18N4O4S/c10-5(7(14)15)2-1-3-13-9(12)18-4-6(11)8(16)17/h5-6H,1-4,10-11H2,(H2,12,13)(H,14,15)(H,16,17)/p+1/t5-,6-/m0/s1 > FBDBZWJNHYXEKT-WDSKDSINSA-O > C9H19N4O4S > 279.337 > 279.112700806 > 7 > 37 > 28.41131109488757 > 1 > 5 > 1 > 0 > (1S)-4-[(E)-[amino({[(2R)-2-amino-2-carboxyethyl]sulfanyl})methylidene]amino]-1-carboxybutan-1-aminium > -2.65 > -5.500234751943857 > -2.77 > 0 > 0 > 1 > 2.460379727670685 > 1.8576865589961105 > 9.727907348894954 > 166.64000000000001 > 78.0265 > 9 > 1 > 5.35e-01 g/l > (2S)-N-methyl-2-[(3S)-3-(2-methylpropyl)-2,5-dioxo-4-(quinolin-3-ylmethyl)-1,4-diazepan-1-yl]-3-(naphthalen-2-yl)propanamide > 0 > DB04671 > experimental > [(1S)-4-[[Amino-[(2R)-2-amino-2-carboxyethyl]sulfanylmethylidene]amino]-1-carboxybutyl]azanium $$$$